Palau Pharma is a product-driven biopharmaceutical company focused on the discovery and development of innovative, improved and safer medicines for the treatment of diseases with identified unmet medical needs in the inflammatory and autoimmune fields. Founded in November 2006 through a spin-out from Grupo Uriach.